Acta Pharmaceutica Sinica B (APSB)
Journal Descriptions
Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high-quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics. The 2022 JIF of APSB is 14.5, ranking No. 5 (Q1 quartile) in category of Pharmacology and Pharmacy. The Editor-in-Chief is Prof. Jian-dong Jiang and Co-Editor-in-Chief is Prof. Rui Wang. APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in SCI, Scopus, Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chinese Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.
Acta Pharmaceutica Sinica B (APSB) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Toxicology, Pharmaceutics , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2211-3835, E-ISSN: 2211-3843, Established: 2012,
- Does Not Provide Crossref DOI
-
Indexed in: Scopus, WoS, DOAJ
-
Not indexed in PubMed, UGC CARE
